Global Pediatric HIV Care Declines as US-Backed Treatment Reaches 77,000 Fewer Children Following Funding Cuts

A significant reduction in United States-backed pediatric HIV treatment has left approximately 77,000 fewer children receiving life-saving care globally. According to a study presented at the AIDS 2026 conference in Rio de Janeiro, there was a 14% year-on-year decline in treatment supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) in the period leading up to October 2025. This downturn is largely attributed to shifts in foreign aid policy and funding cuts implemented during the Trump administration, sparking deep concern among global health advocates about the stability of pediatric care in vulnerable regions.

The research, which analyzed U.S. government data across 21 countries, found that 20 of those nations experienced a marked decrease in access to treatment. South Africa recorded the most drastic decline, with a 45% drop representing roughly 30,000 children who are no longer receiving U.S.-supported antiretroviral therapy. Other nations such as Kenya and Uganda have also seen significant regressions. In Kenya, health advocates report that the reduction in financial support has severely crippled community-based systems that previously ensured children remained in care and received the necessary medical oversight.

While health experts warn that the funding gaps are leading to an increase in cases of advanced HIV among children, the U.S. State Department has formally disputed the study's findings and methodology. Government officials argue that the decline in treatment numbers is not necessarily a failure of aid, but rather an indication of a successful reduction in new HIV infections among children. However, researchers and critics contend that this interpretation overlooks the palpable impact on existing patients and the erosion of the support infrastructure necessary to maintain long-term treatment adherence.

The findings highlight a critical gap in the global response to the HIV/AIDS epidemic, particularly as other international organizations struggle to fill the void left by U.S. retrenchment. Experts at the conference emphasized that without detailed, transparent data and a renewed commitment to pediatric-specific funding, the progress made over the last two decades in managing childhood HIV could be permanently compromised. The situation underscores the sensitivity of global health outcomes to political shifts in donor nations, placing thousands of young lives at risk.